Onur Seda Tural, Boyracı Neslihan, Akyıl Fatma Tokgöz, Sökücü Sinem Nedime, Kara Kaan
Department of Chest Diseases, Health Sciences University, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey.
Respir Med Case Rep. 2022 May 21;38:101667. doi: 10.1016/j.rmcr.2022.101667. eCollection 2022.
Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation and airway inflammation, with a prevalence of 10.1%. Among the many causes of COPD, Smoking is the leading and another big cause is (AATD α1-antitrypsin deficiency)' an inherited disorder. Prevalence of COPD patients is 1.9%. World Health Organization (WHO) advice all COPD patients' AATD rate to be screened at least once during their life.The prevalence of AATD in the general population ranges from 1:2,000-5,000 in parts of Europe and from 1 to 5,000-10,000 in the United States and Canada.
CASE 1: An 81-year-old male patient with COPD. In computed tomography (CT) of the thorax, mass in the right lower lobe and a nodule in the right upper lobe were detected. The biopsy from right bronchial entrance via fiberoptic bronchoscopy (FB) yielded squamous cell carcinoma (SCC). AAT level was 169 mg/dL (ref. range: 90-200 mg/dL). M/P lowell allele was detected in genetic analysis.
CASE 2: A 45-year-old male patient with COPD. Conglomerated lymhadenomegaly in the paratracheal area was detected in CT. The biopsy from mucosal infiltrates initiating from the entrance of the right upper lobe to the anterior segment revealed SCC. His AAT level was 190 mg/dL (ref. range: 90-200 mg/dL) and the genetic analysis demonstrated M/I mutation.
CASE 3: A 64-year-old male COPD patient. In thorax CT, a 24 mm diameter parenchymal nodule in the left lower lobe was detected. Transthoracic fine needle aspiration biopsy from the left lung nodule showed SCC. His AAT level was 196 mg/dL (ref. range: 90-200 mg/dL) and M/P lowell allele was detected in the genetic analysis.
AAT deficiency can cause early-onset of COPD, manifested with emphysema and chronic bronchitis. It has been suggested that AATD is associated with an increased risk of many types of cancer. Although the relationship between AATD or variant carriage and LC histopathology is not clear in the literature, it was detected as squamous cell carcinoma in our cases. We infer that unmeasurable lung damage is more prevalent in heterozygous patients and we believe that sharing our results may draw more attention in this regard.
慢性阻塞性肺疾病(COPD)的特征是持续性气流受限和气道炎症,患病率为10.1%。在导致COPD的众多原因中,吸烟是首要原因,另一个主要原因是(AATDα1-抗胰蛋白酶缺乏症),这是一种遗传性疾病。COPD患者中AATD的患病率为1.9%。世界卫生组织(WHO)建议所有COPD患者一生中至少进行一次AATD筛查。AATD在普通人群中的患病率在欧洲部分地区为1:2000 - 5000,在美国和加拿大为1:5000 - 10000。
病例1:一名81岁的男性COPD患者。胸部计算机断层扫描(CT)显示右下叶有肿块,右上叶有结节。通过纤维支气管镜(FB)从右支气管入口处进行活检,结果为鳞状细胞癌(SCC)。AAT水平为169mg/dL(参考范围:90 - 200mg/dL)。基因分析检测到M/P洛厄尔等位基因。
病例2:一名45岁的男性COPD患者。CT检查发现气管旁区域有融合性淋巴结肿大。从右上叶入口至前段的黏膜浸润处进行活检,结果为SCC。他的AAT水平为190mg/dL(参考范围:90 - 200mg/dL),基因分析显示存在M/I突变。
病例3:一名64岁男性COPD患者。胸部CT检查发现左下叶有一个直径24mm 的实性结节。经胸壁对左肺结节进行细针穿刺活检,结果为SCC。他的AAT水平为196mg/dL(参考范围:90 - 200mg/dL),基因分析检测到M/P洛厄尔等位基因。
AAT缺乏可导致COPD早发,表现为肺气肿和慢性支气管炎。有人提出AATD与多种癌症的风险增加有关。尽管文献中AATD或变异携带者与肺癌组织病理学之间的关系尚不清楚,但在我们的病例中均检测为鳞状细胞癌。我们推断杂合子患者中不可测量的肺损伤更为普遍,我们相信分享我们的结果可能会在这方面引起更多关注。